Discontinued — last reported Q4 '25
Waste Management Acquisitions decreased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $6.71B to $0.00. Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 51.5% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.00M | $1.00M | $64.00M | $9.00M | $1.00M | $197.00M | $170.00M | $34.00M | $84.00M | $21.00M | $31.00M | $11.00M | $232.00M | $539.00M | $6.71B | $3.00M | $363.00M | $29.00M | $0.00 |
| QoQ Change | — | -66.7% | >999% | -85.9% | -88.9% | >999% | -13.7% | -80.0% | +147.1% | -75.0% | +47.6% | -64.5% | >999% | +132.3% | >999% | -100.0% | >999% | -92.0% | -100.0% |
| YoY Change | — | — | — | — | -66.7% | >999% | +165.6% | +277.8% | >999% | -89.3% | -81.8% | -67.6% | +176.2% | >999% | >999% | -72.7% | +56.5% | -94.6% | -100.0% |